methylprednisolone has been researched along with Adenocarcinoma of Lung in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hainaut, P; Vandamme, E | 1 |
| Cao, BS; Gu, YC; Liu, Y; Xie, C | 1 |
| Hisamatsu, Y; Morinaga, R; Ohtani, S; Shirao, K; Watanabe, E | 1 |
| Ikeda, T; Ishii, H; Kinoshita, Y; Kushima, H; Sasaki, T; Ueda, Y | 1 |
| Abe, K; Arai, H; Isono, A; Nakamura, N; Saito, K; Toyota, H | 1 |
| Kanda, T; Kubo, M; Mitsui, H; Nawata, T; Oishi, K; Omoto, M; Yano, M | 1 |
| Ding, X; Fang, L; Jiang, G; Liu, M; Liu, Y; Wang, Y; Wei, H; Yang, S | 1 |
| Reed, VA; Rizvi, N | 1 |
8 other study(ies) available for methylprednisolone and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Eosinophilic Fasciitis Unmasking a Lung Cancer.
Topics: Adenocarcinoma of Lung; Anti-Inflammatory Agents; Edema; Eosinophilia; Fasciitis; Humans; Immunosuppressive Agents; Lung Neoplasms; Male; Methotrexate; Methylprednisolone; Middle Aged | 2022 |
[Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
Topics: Adenocarcinoma of Lung; Adrenocorticotropic Hormone; Aged; B7-H1 Antigen; Humans; Hydrocortisone; Hyponatremia; Hypopituitarism; Immune Checkpoint Inhibitors; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Nausea; Pituitary Gland; Pneumonia; Prednisone; Programmed Cell Death 1 Receptor; Prolactin | 2022 |
Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab.
Topics: Adenocarcinoma of Lung; Adrenal Gland Neoplasms; Antineoplastic Agents, Immunological; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Febrile Neutropenia; Granulocyte Colony-Stimulating Factor; Humans; Liver Diseases; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Nivolumab; Prednisolone | 2020 |
A 63-Year-Old Woman With an Acute Exacerbation of Interstitial Pneumonia.
Topics: Adenocarcinoma of Lung; Biopsy; Female; Glucocorticoids; Humans; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphadenopathy; Methylprednisolone; Middle Aged; Sjogren's Syndrome; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Inflammatory Bowel Disease in an Elderly Woman After Nivolumab Administration.
Topics: Adenocarcinoma of Lung; Aged, 80 and over; Antineoplastic Agents, Immunological; Biopsy; Colon; Colonoscopy; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Lung Neoplasms; Methylprednisolone; Nivolumab | 2017 |
Dermatomyositis Complicated by Digital Ischemia and Lung Adenocarcinoma in a Patient with Positive Anti-signal Recognition Particle Antibodies.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anti-Inflammatory Agents; Antibodies; Arthritis, Rheumatoid; Asian People; Autoimmune Diseases; Dermatologic Agents; Dermatomyositis; Female; Humans; Ischemia; Lung Neoplasms; Methotrexate; Methylprednisolone; Middle Aged; Signal Recognition Particle; Sjogren's Syndrome; Treatment Outcome | 2018 |
Pulmonary adenocarcinoma associated with Guillain-Barré syndrome: A case report.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Glucocorticoids; Guillain-Barre Syndrome; Humans; Lung; Lung Neoplasms; Male; Methylprednisolone; Paraneoplastic Syndromes; Tomography, X-Ray Computed | 2018 |
Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lung; Lung Neoplasms; Methylprednisolone; Pneumonia; Prednisone; Programmed Cell Death 1 Receptor; Symptom Flare Up; Tomography, X-Ray Computed; Treatment Outcome | 2019 |